Physician profile
Jonathan Capelle
NPI 1982863254
$4,657.42
in general payments reported to CMS, 2019-2025
22 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $298 · 2021: $404 · 2022: $1,571 · 2023: $593 · 2024: $623 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.47 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,708.63 | 2022-2024 | |
| Smith+Nephew, INC. | $709.83 | 2019-2025 | Ultrabutton, Q-Fix, Na |
| Stryker Corporation | $391.34 | 2020-2025 | Mako |
| Aroa Biosurgery Incorporated | $255.01 | 2025 | |
| Goode Surgical INC | $249.02 | 2023 | |
| Zimmer Biomet Holdings, INC. | $240.14 | 2020-2025 | Gel-One Cross-Linked Hyaluronate |
| Pacira Therapeutics, INC. | $225.49 | 2019-2021 | |
| Arthrex, INC. | $214.95 | 2024 | |
| Depuy Synthes Sales INC. | $148.72 | 2025 | Attune, Velys, Inhance |
| Bioventus LLC | $134.72 | 2019-2025 | Durolane, Durolane |
| Anika Therapeutics, INC. | $81.69 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $80.72 | 2021-2024 | Zilretta, Iovera, Exparel |
| Horizon Therapeutics Plc | $43.79 | 2020-2021 | |
| Vericel Corporation | $31.98 | 2022-2023 | Maci |
| Pfizer INC. | $26.90 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $21.03 | 2021-2022 | |
| Endo USA, INC. | $20.54 | 2025 | Xiaflex |
| Dynasplint Systems INC. | $16.94 | 2024 | Dynasplint |
| Radius Health, INC. | $15.50 | 2022 | |
| Medacta USA, INC. | $14.73 | 2024 | |
| Solventum Corporation | $13.95 | 2025 | V.A.C. Dermatac, Prevena, V.A.C.Ulta |
| Medtronic USA, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Capelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.